The estimated Net Worth of Kenneth G Condon is at least $260 mil dollars as of 15 December 2005. Kenneth Condon owns over 13,663 units of Insmed Inc stock worth over $7,276 and over the last 21 years Kenneth sold INSM stock worth over $253,031.
Kenneth has made over 9 trades of the Insmed Inc stock since 2003, according to the Form 4 filled with the SEC. Most recently Kenneth sold 13,663 units of INSM stock worth $24,593 on 15 December 2005.
The largest trade Kenneth's ever made was selling 35,000 units of Insmed Inc stock on 10 October 2003 worth over $112,350. On average, Kenneth trades about 5,263 units every 46 days since 2003. As of 15 December 2005 Kenneth still owns at least 100 units of Insmed Inc stock.
You can see the complete history of Kenneth Condon stock trades at the bottom of the page.
Kenneth's mailing address filed with the SEC is , , , , .
Over the last 21 years, insiders at Insmed Inc have traded over $46,121,705 worth of Insmed Inc stock and bought 1,080,212 units worth $8,226,993 . The most active insiders traders include Llc Fmr, William Lewis y Dennis M Lanfear. On average, Insmed Inc executives and independent directors trade stock every 38 days with the average trade being worth of $2,452,158. The most recent stock trade was executed by Orlov S Nicole Schaeffer on 10 September 2024, trading 37,575 units of INSM stock currently worth $407,689.
insmed is a global biopharmaceutical company on a mission to transform the lives of patients with serious and rare diseases. the company is dedicated to developing and bringing to market therapies that make a real difference in patients’ lives, while striving to understand and enhance the entire patient experience, from diagnosis and treatment to everyday living. headquartered in bridgewater, nj, we are a rapidly growing company with offices in seven countries.
Insmed Inc executives and other stock owners filed with the SEC include: